---
document_datetime: 2023-09-21 18:47:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/emtricitabinetenofovir-disoproxil-zentiva-epar-all-authorised-presentations_en.pdf
document_name: emtricitabinetenofovir-disoproxil-zentiva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3284002
conversion_datetime: 2025-12-28 19:11:56.559098
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

## EU/1/16/1148/001 Emtricitabine/Tenofovir disoproxil Zentiva 200 mg / 245 mg Film-coated tablet Oral use bottle (HDPE) 30 tablets EU/1/16/1148/002 Emtricitabine/Tenofovir disoproxil Zentiva 200 mg / 245 mg Film-coated tablet Oral use bottle (HDPE) 90 (3 x 30) tablets